Dr Vishwanath S | Medical Oncologist in Bangalore | Book Appointment
No Image

Dr Vishwanath S

750

Consultation

Medical Registration Verified

About Us

  • Dr. Vishwanath S is a highly accomplished medical oncologist with a fellowship from the University of Texas, MD Anderson Cancer Center in Houston, TX, USA. He has an outstanding academic record with gold medals in DM, Medical Oncology (Kidwai Memorial Institute of Oncology) and MD, Internal Medicine (Kasturba Medical College). He specializes in Lymphoma/ Multiple Myeloma, Leukemias and solid cancers (Breast, Gynaecological, Lung, Head and Neck, GI and Sarcomas). He has published widely in journals with high impact factor and has over 40 international publications. He was won several prestigious awards including an Abstract Achievement Award from the American Society of Hematology (ASH). Based on his achievements, the Apollo Hospitals Educational and Research Foundation (AHERF) bestowed on him the title of Professor in the Department of Medical Oncology in 2018.

Show More

Information

Apollo Hospitals, Bangalore

Bangalore

Old No. 28, 1, Platform Rd, Near Mantri Square Mall, Seshadripuram, Bengaluru, Karnataka 560020

Common questions & answers

  • Who is Dr Vishwanath S ?
  • Dr Vishwanath S is a Medical Oncologist with experience of 5 years. Dr Vishwanath S 's educational qualifications include MBBS MD (General Medicine) DM (Medical Oncology) Dr Vishwanath S. is a member of Karnataka Medical Council American Society of Clinical Oncology (ASCO) American Society Of Hematology Indian Society of Medical and Paediatric Oncology (ISMPO) . Dr Vishwanath S's areas of interest include Solid malignancies,Lymphoma,Myeloma,Head and neck cancer, Breast cancer, Lung Cancer, GI Cancer, Gynaecological cancers, Sarcomas
  • Where does Dr Vishwanath S practice?
  • Dr Vishwanath S practices at Apollo Hospitals, Bangalore
  • Why do patients visit Dr Vishwanath S?
  • Patients frequently visit Dr Vishwanath S for Solid malignancies,Lymphoma,Myeloma,Head and neck cancer, Breast cancer, Lung Cancer, GI Cancer, Gynaecological cancers, Sarcomas
  • What is Dr Vishwanath S's rating?
  • Dr Vishwanath S is a highly rated Medical Oncologist with positive feedback from most patients treated.
  • What is Dr Vishwanath S's education qualification?
  • Dr Vishwanath S has the following qualifications: MBBS from MAHE, 2005 MD (General Medicine) from Kasturba Medical College DM (Medical Oncology) from Kidwai Memorial Institute of Oncology Clinical Fellow at Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas Fellowship at MD Anderson Cancer Center
  • What does Dr Vishwanath S specialize in?
  • Dr Vishwanath S specializes as a Medical Oncologist with special interest in Solid malignancies,Lymphoma,Myeloma,Head and neck cancer, Breast cancer, Lung Cancer, GI Cancer, Gynaecological cancers, Sarcomas .
  • How many years of experience does Dr Vishwanath S have?
  • Dr Vishwanath S has an overall experience of 5 years as a Medical Oncologist.
  • How can I book an appointment with Dr Vishwanath S?
  • You can book an appointment with Dr Vishwanath S by clicking "Book Appointment" on top-right. We shall shortly confirm your booking upon receiving your request.

Education

  • MBBS from MAHE, 2005
  • MD (General Medicine) from Kasturba Medical College
  • DM (Medical Oncology) from Kidwai Memorial Institute of Oncology
  • Clinical Fellow at Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas
  • Fellowship at MD Anderson Cancer Center

Paper & Presentations

  • 2006-Oral Presentation: Melioidosis, an emerging infectious disease Р Association of Physicians of India, Karnataka Chapter, Bangalore, India2004-Neurology Quiz (2nd Place), NIMHANS, Bangalore, Karnataka, India
  • Abstracts:
  • 1. Kristin S, Sathyanarayanan et al. Analyzing Patient Characteristics Who Received (DA) EPOCH- R for High Risk Diffuse Large B-Cell Lymphoma: MD Anderson Cancer Center Experience. Abstract at ASH 2016, Dec 3-6, San Diego, USA
  • 2. Sathyanarayanan et al. High risk DLBCL: A comparison of aggressive sub types treated with DA EPOCH R: MD Anderson Cancer Center Experience, Oral Abstract at ASH 2016, Dec 3-6, San Diego, USA
  • 3. Sathyanarayanan V, Issa AK, Ahmed MA, et al. DA-EPOCH-R for high risk diffuse large Bcell lymphoma (DLBCL): The University of Texas MD Anderson Experience. Abstract #88556. Presented at the 2016 ASH Meeting on Lymphoma Biology, June 20, 2016; Colorado Springs,CO.
  • 4. Sathyanarayanan V, Fayad L, Nastoupil LJ, et al: Phase I/II study of lenalidomide and obinutuzumab with CHOP for diffuse large B-cell lymphoma. 2016 Pan Pacific Lymphoma Conference. Poster. Presented July 18, 2016.
  • 5. Amir Issa, Vishwanath Sathyanarayanan, Michelle A. Fanale, Yasuhiro Oki, Fredrick B. Hagemeister, Sattva Swarup Neelapu, Loretta J. Nastoupil, Nathan Hale Fowler, Francesco Turturro, Mansoor Noorani, Mohamed Amin Ahmed, Richard Eric Davis, Maria Alma Rodriguez, Michael Wang, Lei Feng, Ken H Young, Timothy McDonnell, Chelsea Camille Pinnix, Luis Fayad, Jason R. Westin. Outcomes of diffuse large b-cell lymphoma with MYC and/or BCL2 protein expression treated with intensive chemotherapy. J Clin Oncol 34, 2016 (suppl; abstr 7563)
  • 6. Vishwanath Sathyanarayanan, Dai Chihara, Michelle A. Fanale, Colleen M Costelloe, Elham Ghonimi, Chan Shen, Francisco Vega, Bouthaina Shbib Dabaja, Yasuhiro Oki, Shouhao Zhou, Chuang Hubert. Prognostic value of PET-CT in early stage Hodgkin Lymphoma (HL) using updated 5 point scoring system. J Clin Oncol 34, 2016 (suppl; abstr e19013)
  • 7. Jason R. Westin, Yasuhiro Oki, Luis Fayad, Loretta J. Nastoupil, Francesco Turturro, Frederick B. Hagemeister, Vishwanath Sathyanarayanan, Ken H Young, Timothy McDonnell, Hubert Chuang, Shouhao Zhou, Sattva Swarup Neelapu, Richard Eric Davis. Rituximab, lenalidomide, and ibrutinib alone and combined with dose adjusted chemotherapy for patients with high risk diffuse large Bcell lymphoma. J Clin Oncol 34, 2016 (suppl; abstr TPS7575)
  • 8. Vishwanath Sathyanarayanan, K.C. Lakshmaiah, Kadabur Nagendrappa Lokesh, Clementina Rama Rao, Suresh TM, Kanaka Govind Babu, Premalata Chennagiri, Loknatha D, Linu Jacob Abraham, Suresh Babu. Ki 67 and Bcl 2 in DLBCL. ISMPOCON 2014 Dec 26-28, 2014, Kolkata, India.
  • 9. Vishwanath Sathyanarayanan, K.C. Lakshmaiah, Kadabur Nagendrappa Lokesh, Clementina Rama Rao, Suresh TM, Kanaka Govind Babu, Premalata Chennagiri, Loknatha D, Linu Jacob Abraham, Suresh Babu. Outcomes in GCB vs. Non GCB DLBCL from a tertiary care center in
  • 10. South India: SAARC International Conference of SAARC Federation of Oncologists, 28-30 Nov 2014, New Delhi, India.
  • 11. Vishwanath Sathyanarayanan, K.C. Lakshmaiah, Kadabur Nagendrappa Lokesh, Clementina Rama Rao, Suresh TM, Kanaka Govind Babu, Premalata Chennagiri, Loknatha D, Linu Jacob Abraham, Suresh Babu. Mantle cell lymphoma (MCL): A single-center experience from a tertiary care institute in south India. J Clin Oncol 32, 2014 (suppl; abstr e19547).
  • 12. Vishwanath Sathyanarayanan, Lakshmaiah KC, Lokanatha D, Govind Babu K, Suresh TM,Linu Abraham Jacob, Suresh Babu M.C. An Unusual Case Of Paclitaxel Induced Reversible Cardiac Dysfunction. Presented at ICON 2014, Bhopal, India.
  • 13. Vishwanath Sathyanarayanan, Lokesh KN, Lakshmaiah KC, Vineetha Unnikrishnan, Clementina Rama Rao, Suresh TM, Govinda Babu K, Lokanatha D, Linu Jacob Abraham, Suresh Babu. Primary Central Nervous System Lymphoma Р a single centre experience from south India. Poster presented at 1st Indian Cancer Congress, New Delhi, India ( Nov 21-24, 2013). Published in abstract form in Indian Journal of Cancer Vol 50, Sup 1, Nov 2013.
  • 14. Saravu K, Ramamoorthy, Vishwanath Sathyanarayanan et al. Melioidosis: Yet to get recognized in India. Paper presented at: VIth World Melioidosis Congress 2010, Nov 30- Dec 3, 2010; Townsville, Australia.
  • 15. Saravu K, Mukhopadhyay C, Vandana KE, VishwanathSathyanarayanan et al. Melioidosis masquerading malignancy. Paper presented at: VIth World Melioidosis Congress 2010, Nov 30- Dec 3, 2010; Townsville, Australia.
  • 16. Vishwanath Sathyanarayanan, Abdul Razak, Kavitha Saravu. Brucella: A great imitator. Paper presented at: 59th Annual meeting of the American Society of Tropical Medicine and Hygiene, Nov 3-7, 2010 Atlanta, USA.
  • 17. Kavitha S, Mukhopadhyay C, Vishwanath Sathyanarayanan et al. Melioidosis in India: Is it the tip of the iceberg? Paper presented at: 13th International Conference of Infectious Diseases, Jun 19- 22, 2008; Kuala Lampur, Malyasia.
  • 18. Kavitha S, Vishwanath Sathyanarayanan et al. Melioidosis: A case series from South India. Paper presented at: 5th World Melioidosis Congress; 2007 Nov 21-23, 2007; Khon Kaen, Thailand.
  • 19. Vishwanath Sathyanarayanan, Saravu K. Hyperglycemia and short term prognosis in stroke. Paper presented at: Annual courses in clinical neurosciences; 2007 Feb 16-17; Chennai, India.
  • 20. Vishwanath Sathyanarayanan. Hepatorenal syndrome. Paper presented at Indian Society of Nephrology Southern Chapter; 2007 Feb; Hyderabad, India.
  • 21. Vishwanath Sathyanarayanan, Rao SN. A rare case report of combined hepatic cysticercosis and neurotuberculosis in an immunocompetent adult. Paper presented at: Association of Physicians of India, Karnataka Chapter; 2006 May; Bangalore, India.
  • 22. Vishwanath Sathyanarayanan, Saravu K. Melioidosis, an emerging infectious disease. Paper presented at: Association of Physicians of India, Karnataka Chapter; 2006 May; Bangalore, India
  • 23. Vishwanath Sathyanarayanan, Balasubramanian R. A rare case of combined herpetic and candidial esophagitis in an immunocompetent adult. Paper presented at:Association of Physicians of India, Karnataka Chapter; 2006 May; Bangalore, India
  • 24. Vishwanath Sathyanarayanan. Prevention of Chronic Kidney Disease. Paper presented At: Indian Society of Nephrology Southern Chapter; 2006 Feb; Trivandrum, India
  • Chairperson/Organizer of conference/CME:
  • CME on lymphomas: March 25, 2018, Bangalore, India. ISP program involving Dr. Fredrick Hagemeister, Professor in the department of Lymphoma, MD Anderson Cancer Center, Houston, TX
  • Speaker in National/International Conferences:
  • 1. ASH 2016, San Diego: oral presentation on DA-EPOCH R in DLBCL
  • 2. Immuno-oncology- clinician's perspective: National Immuno oncology master class, May 21-22, Bangalore, India

Memberships

  • Karnataka Medical Council
  • American Society of Clinical Oncology (ASCO)
  • American Society Of Hematology
  • Indian Society of Medical and Paediatric Oncology (ISMPO)

Awards and Recognitions

  • Gold Medal, MD General Medicine, Kasturba Medical College, Manipal - 2008
  • Gold Medal DM Medical Oncology, Kidwai Memorial Institute of Oncology,Rajiv Gandhi University of Health Sciences, Bangalore, India - 2015
  • Travel Grant, Pan Pacific Lymphoma Conference, Kauai - 2016
  • Consolation Prize: Outcomes in GCB vs. Non GCB DLBCL from a tertiary care center in South India - 2014
  • Neurology Quiz (2nd Place), NIMHANS, Bangalore, Karnataka, India - 2006

Experience

  • Consultant Medical Oncologist at Apollo Hospital
  • Diplomate of National Board (DNB)Teacher, Apollo Hospitals and Education Research Foundation (AHERF)
  • Clinical Fellow in the Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Assistant Professor in the Department of Internal Medicine, Kasturba Medical College, Manipal University, Manipal, India

Areas of interest

  • Solid malignancies,Lymphoma,Myeloma,Head and neck cancer, Breast cancer, Lung Cancer, GI Cancer, Gynaecological cancers, Sarcomas

General Availability

Mon Tue Wed Thu Fri Sat Sun
Pr 12pm - - -
12pm - 3pm -
After 5pm - - - - -

Reliability assured with certified labs


Select Address

Select Patient